The University of Chicago Header Logo

Philip Connell

Concepts (273)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rad51 Recombinase
13
2021
81
3.530
Why?
Homologous Recombination
9
2022
57
2.160
Why?
Radiation Injuries
3
2019
160
1.200
Why?
DNA Repair
12
2021
363
1.090
Why?
Radiotherapy
5
2019
325
1.010
Why?
Endometrial Neoplasms
11
2001
243
0.920
Why?
Small Molecule Libraries
3
2016
74
0.850
Why?
Enzyme Inhibitors
2
2019
641
0.750
Why?
Morpholines
3
2015
64
0.750
Why?
Neoplasms
7
2016
3382
0.740
Why?
Transcription Factor RelB
1
2022
3
0.730
Why?
Benzamides
3
2015
260
0.660
Why?
Sulfonamides
3
2015
352
0.600
Why?
Neoplasms, Radiation-Induced
2
2019
96
0.600
Why?
NF-kappa B
1
2022
424
0.590
Why?
Pyrroles
4
2019
166
0.580
Why?
Quinoxalines
1
2019
51
0.570
Why?
Antineoplastic Agents
5
2016
2386
0.560
Why?
PTEN Phosphohydrolase
1
2019
154
0.550
Why?
Carcinoma, Non-Small-Cell Lung
7
2023
1177
0.510
Why?
Anthracyclines
1
2017
31
0.500
Why?
DNA Helicases
2
2015
94
0.500
Why?
Sarcoma
3
2019
222
0.470
Why?
Germ-Line Mutation
1
2019
404
0.450
Why?
Neoplasm, Residual
1
2017
205
0.450
Why?
DNA Replication
4
2019
169
0.450
Why?
Enzyme Activation
2
2013
679
0.440
Why?
Lung Neoplasms
8
2023
2474
0.440
Why?
Head and Neck Neoplasms
2
2016
1091
0.420
Why?
Radiotherapy, Conformal
2
2007
88
0.410
Why?
Drug Therapy
1
2014
67
0.400
Why?
Adenocarcinoma
6
2012
1215
0.400
Why?
Radiation Injuries, Experimental
1
2013
41
0.390
Why?
Ataxia Telangiectasia Mutated Proteins
1
2013
65
0.390
Why?
Rec A Recombinases
1
2013
14
0.390
Why?
Humans
59
2023
98799
0.380
Why?
Gene Expression Regulation, Neoplastic
3
2019
1400
0.380
Why?
Maleimides
1
2012
26
0.380
Why?
Nuclear Proteins
2
2015
757
0.370
Why?
DNA Damage
3
2017
400
0.360
Why?
Radiotherapy, Adjuvant
8
2009
325
0.360
Why?
Escherichia coli Proteins
1
2013
186
0.350
Why?
Indoles
1
2013
340
0.340
Why?
DNA Breaks, Double-Stranded
3
2022
73
0.340
Why?
Cisplatin
4
2009
578
0.340
Why?
DNA-Binding Proteins
4
2021
1275
0.330
Why?
HEK293 Cells
4
2019
724
0.310
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2021
2666
0.300
Why?
Protein Binding
5
2019
1564
0.300
Why?
Neoplasm Staging
15
2023
2087
0.290
Why?
Chemotherapy, Adjuvant
5
2009
527
0.290
Why?
Cell Survival
4
2019
1018
0.290
Why?
Neoplasm Recurrence, Local
8
2023
1538
0.290
Why?
Molecular Structure
3
2019
305
0.280
Why?
Breast Neoplasms
3
2021
3303
0.270
Why?
Apoptosis
3
2019
1754
0.270
Why?
DNA
6
2021
1274
0.270
Why?
Prognosis
13
2021
4139
0.270
Why?
Radiotherapy, High-Energy
1
2007
43
0.270
Why?
Cranial Irradiation
1
2007
42
0.260
Why?
Structure-Activity Relationship
3
2019
429
0.250
Why?
Female
35
2021
51997
0.250
Why?
Follow-Up Studies
11
2021
4049
0.250
Why?
Lacrimal Duct Obstruction
1
2006
2
0.240
Why?
Nasolacrimal Duct
1
2006
3
0.240
Why?
Aged
25
2021
21986
0.240
Why?
Genomic Instability
3
2017
92
0.240
Why?
Intubation
1
2006
21
0.240
Why?
Cell Line, Tumor
5
2019
2913
0.230
Why?
Retrospective Studies
19
2023
11104
0.220
Why?
Ovariectomy
3
2001
98
0.220
Why?
Middle Aged
27
2021
29642
0.210
Why?
Hysterectomy
3
2001
175
0.200
Why?
Adult
23
2021
29698
0.200
Why?
Drug Resistance, Neoplasm
3
2021
671
0.190
Why?
Multiprotein Complexes
2
2021
107
0.190
Why?
Genes, p53
1
2003
108
0.190
Why?
Attitude to Health
1
2004
217
0.190
Why?
Survival Analysis
9
2017
1530
0.190
Why?
Fractures, Spontaneous
1
2023
16
0.190
Why?
Combined Modality Therapy
6
2013
1754
0.190
Why?
HIV-1
2
2015
179
0.180
Why?
Sexually Transmitted Diseases
1
2004
115
0.180
Why?
Adenoviridae
1
2003
341
0.180
Why?
Carcinoma, Transitional Cell
1
2003
158
0.170
Why?
Treatment Outcome
13
2017
9806
0.170
Why?
Brain Neoplasms
1
2007
845
0.170
Why?
Pelvic Neoplasms
1
2001
43
0.170
Why?
Loss of Function Mutation
1
2021
53
0.170
Why?
Aged, 80 and over
15
2021
7461
0.170
Why?
Biomarkers, Tumor
2
2021
1786
0.160
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2021
110
0.160
Why?
Orthopedics
1
2023
143
0.160
Why?
Small Cell Lung Carcinoma
1
2023
144
0.160
Why?
Brachytherapy
6
2001
139
0.160
Why?
Orthopedic Procedures
1
2023
163
0.160
Why?
Genetic Therapy
1
2003
374
0.160
Why?
Peptides
1
2004
671
0.160
Why?
Extremities
2
2013
173
0.150
Why?
Neoplasm Invasiveness
5
2001
583
0.150
Why?
Ossification, Heterotopic
1
2019
34
0.150
Why?
Adnexa Uteri
1
1999
11
0.150
Why?
Cycloaddition Reaction
1
2019
6
0.150
Why?
Radiotherapy Dosage
4
2009
478
0.140
Why?
Cell Cycle Proteins
1
2021
420
0.140
Why?
Urinary Bladder Neoplasms
1
2003
403
0.140
Why?
Prostatic Neoplasms
2
2001
1846
0.140
Why?
Naphthyridines
1
2019
26
0.140
Why?
Soft Tissue Neoplasms
1
2019
127
0.140
Why?
Triple Negative Breast Neoplasms
1
2021
218
0.140
Why?
Survival Rate
7
2021
2057
0.140
Why?
Radiobiology
1
2018
15
0.140
Why?
Oxidation-Reduction
1
2019
417
0.130
Why?
Lymphatic Metastasis
4
2012
519
0.130
Why?
Prostate-Specific Antigen
1
1999
356
0.130
Why?
MCF-7 Cells
2
2015
123
0.130
Why?
Male
17
2021
47475
0.130
Why?
Dose-Response Relationship, Radiation
3
2007
193
0.130
Why?
Pneumonectomy
2
2011
222
0.120
Why?
Preoperative Period
1
2017
103
0.120
Why?
Endosonography
1
2017
103
0.120
Why?
Risk
3
2004
662
0.120
Why?
Bronchi
1
2017
229
0.120
Why?
Disease-Free Survival
6
2011
1196
0.110
Why?
Immunotherapy
1
2021
831
0.110
Why?
Neuroblastoma
1
2019
410
0.110
Why?
Doxorubicin
2
2009
285
0.110
Why?
Neoplasm Metastasis
3
2011
1102
0.110
Why?
Radiotherapy, Image-Guided
2
2012
66
0.100
Why?
Carcinoma, Squamous Cell
3
2012
1107
0.100
Why?
Neoplasm Transplantation
1
2014
400
0.100
Why?
Fluorometry
1
2013
30
0.100
Why?
RNA Interference
1
2014
388
0.090
Why?
Fluorescence Resonance Energy Transfer
1
2013
102
0.090
Why?
Mitomycin
1
2012
30
0.090
Why?
Mice, Nude
1
2014
829
0.090
Why?
Chicago
3
2001
1520
0.090
Why?
Actuarial Analysis
3
2001
60
0.090
Why?
DNA, Single-Stranded
2
2011
96
0.090
Why?
Uterine Cervical Neoplasms
3
2000
326
0.090
Why?
Cross-Linking Reagents
1
2012
89
0.090
Why?
Protein Subunits
1
2012
121
0.090
Why?
Carcinoma, Large Cell
1
2012
38
0.090
Why?
Stress, Physiological
1
2014
259
0.090
Why?
Virus Integration
1
2011
17
0.090
Why?
Cystadenocarcinoma, Papillary
2
2001
9
0.090
Why?
Antibiotics, Antineoplastic
1
2012
111
0.090
Why?
Life Tables
2
2001
46
0.090
Why?
Dinoprostone
1
2011
79
0.080
Why?
Esophageal Neoplasms
2
2007
355
0.080
Why?
Cysteine
1
2012
151
0.080
Why?
Signal Transduction
1
2022
3642
0.080
Why?
Caspase 3
1
2011
161
0.080
Why?
Radiation Oncology
1
2013
130
0.080
Why?
Age Factors
3
2007
1976
0.080
Why?
Multivariate Analysis
4
2000
1007
0.080
Why?
Adenocarcinoma, Clear Cell
2
2001
64
0.080
Why?
Neoadjuvant Therapy
2
2021
477
0.080
Why?
Mice
3
2019
12762
0.080
Why?
Animals
4
2019
29045
0.080
Why?
Child
2
2016
7771
0.080
Why?
Chromatin
1
2014
465
0.080
Why?
Down-Regulation
1
2011
529
0.080
Why?
Binding Sites
1
2012
1162
0.080
Why?
Neoplasms, Experimental
1
2011
263
0.080
Why?
Epirubicin
1
2009
14
0.070
Why?
Ifosfamide
1
2009
37
0.070
Why?
Amino Acid Sequence
2
2021
2011
0.070
Why?
History, 19th Century
1
2009
57
0.070
Why?
Necrosis
1
2009
225
0.070
Why?
Enzyme Stability
1
2008
49
0.070
Why?
Postoperative Complications
1
2019
2719
0.070
Why?
Tumor Burden
1
2009
330
0.070
Why?
History, 21st Century
1
2009
196
0.070
Why?
Drug Administration Schedule
1
2009
837
0.070
Why?
Radiosurgery
1
2011
352
0.070
Why?
History, 20th Century
1
2009
323
0.060
Why?
Platinum Compounds
1
2007
29
0.060
Why?
Treatment Failure
2
2006
300
0.060
Why?
Ligands
1
2008
492
0.060
Why?
Genes, BRCA2
1
2008
162
0.060
Why?
Quality of Life
1
2016
1904
0.060
Why?
Glutamates
1
2007
85
0.060
Why?
Dacryocystorhinostomy
1
2006
3
0.060
Why?
Silicones
1
2006
21
0.060
Why?
Guanine
1
2007
194
0.060
Why?
Carboplatin
1
2007
331
0.060
Why?
Fibroblasts
1
2008
767
0.060
Why?
London
1
2004
15
0.050
Why?
Cohort Studies
3
2017
3242
0.050
Why?
Bacteriophage M13
1
2004
8
0.050
Why?
Safe Sex
1
2004
24
0.050
Why?
Pregnancy in Adolescence
1
2004
27
0.050
Why?
Condoms
1
2004
41
0.050
Why?
Sex Distribution
1
2004
176
0.050
Why?
Radiation, Ionizing
1
2004
123
0.050
Why?
Peptide Library
1
2004
87
0.050
Why?
Risk Reduction Behavior
1
2004
102
0.050
Why?
Adolescent
3
2007
10168
0.050
Why?
Awareness
1
2004
93
0.050
Why?
Radiation Tolerance
1
2004
179
0.050
Why?
Immunohistochemistry
1
2007
1818
0.050
Why?
Focus Groups
1
2004
215
0.050
Why?
Pilot Projects
1
2006
978
0.050
Why?
Stents
1
2006
442
0.050
Why?
Clinical Trials, Phase I as Topic
1
2003
154
0.050
Why?
Recombinant Fusion Proteins
1
2004
557
0.050
Why?
Infant, Newborn
1
2008
2556
0.040
Why?
Genetic Vectors
1
2003
425
0.040
Why?
HIV Infections
1
2011
1024
0.040
Why?
Carcinoma, Adenosquamous
1
2001
12
0.040
Why?
Platinum
1
2021
68
0.040
Why?
Vaginal Neoplasms
1
2001
86
0.040
Why?
Sequence Homology, Amino Acid
1
2021
403
0.040
Why?
China
1
2021
283
0.040
Why?
Cell Proliferation
2
2019
1801
0.040
Why?
Dose-Response Relationship, Drug
3
2016
1949
0.040
Why?
Infant
1
2007
3368
0.040
Why?
Cryoelectron Microscopy
1
2021
143
0.040
Why?
Vascular Neoplasms
1
2000
21
0.040
Why?
Antineoplastic Agents, Hormonal
1
2001
161
0.040
Why?
Nucleic Acid Conformation
1
2021
348
0.040
Why?
Young Adult
2
2013
7598
0.040
Why?
Carcinoma
2
2000
442
0.040
Why?
Child, Preschool
1
2007
4053
0.040
Why?
Neoplasms, Multiple Primary
1
2000
100
0.040
Why?
Molecular Sequence Data
1
2004
2897
0.040
Why?
Socioeconomic Factors
2
1999
675
0.040
Why?
Risk Assessment
1
2007
2604
0.040
Why?
Knee Prosthesis
1
2019
26
0.040
Why?
Cell Line
2
2016
2484
0.040
Why?
Oxygen
1
2004
777
0.040
Why?
Molecular Dynamics Simulation
1
2021
329
0.040
Why?
Analysis of Variance
1
2001
890
0.040
Why?
Protein Conformation
1
2021
933
0.040
Why?
Vagina
1
2000
188
0.040
Why?
Heterografts
1
2019
121
0.030
Why?
Hodgkin Disease
1
1999
144
0.030
Why?
Arthroplasty, Replacement, Knee
1
2019
122
0.030
Why?
Pregnancy
1
2004
3286
0.030
Why?
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
1
2015
17
0.030
Why?
Radiation Dosage
2
2011
233
0.030
Why?
Stilbenes
1
2015
26
0.030
Why?
Aptamers, Nucleotide
1
2015
25
0.030
Why?
Mutagens
1
2015
30
0.030
Why?
Replication Protein A
1
2015
16
0.030
Why?
Virus Internalization
1
2015
46
0.030
Why?
Remission Induction
2
2011
764
0.030
Why?
DNA, Neoplasm
1
2015
267
0.030
Why?
Virus Replication
1
2015
292
0.020
Why?
Ovarian Neoplasms
1
2000
829
0.020
Why?
RNA, Small Interfering
1
2015
573
0.020
Why?
HIV Integrase
1
2011
5
0.020
Why?
SEER Program
1
2013
252
0.020
Why?
Four-Dimensional Computed Tomography
1
2011
18
0.020
Why?
Neoplasm Grading
1
2013
425
0.020
Why?
Gene Expression
1
2015
1322
0.020
Why?
Maximum Tolerated Dose
1
2011
265
0.020
Why?
Time Factors
1
1999
5586
0.020
Why?
Risk Factors
1
2001
6295
0.020
Why?
Recombination, Genetic
1
2011
424
0.020
Why?
Chemoradiotherapy
1
2011
337
0.020
Why?
Pemetrexed
1
2007
76
0.020
Why?
Disease Progression
1
2011
1621
0.020
Why?
Area Under Curve
1
2007
341
0.010
Why?
Image Processing, Computer-Assisted
1
2012
1305
0.010
Why?
Prospective Studies
1
2012
4837
0.010
Why?
Models, Biological
1
2008
1806
0.010
Why?
Morbidity
1
2000
163
0.010
Why?
Fever
1
2000
123
0.010
Why?
Gastrointestinal Diseases
1
2000
156
0.010
Why?
Mutation
1
2008
4443
0.010
Why?
Hospitalization
1
2000
993
0.010
Why?
Connell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (273)
Explore
_
Co-Authors (45)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_